Affiliation:
1. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
2. Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
Abstract
ABSTRACT
Chlamydia trachomatis
infection is the most prevalent bacterial sexually transmitted infection and can cause significant reproductive morbidity in women. There is insufficient knowledge of
C. trachomatis
-specific immune responses in humans, which could be important in guiding vaccine development efforts. In contrast, murine models have clearly demonstrated the essential role of T helper type 1 (Th1) cells, especially interferon gamma (IFN-γ)-producing CD4
+
T cells, in protective immunity to chlamydia. To determine the frequency and magnitude of Th1 cytokine responses elicited to
C. trachomatis
infection in humans, we stimulated peripheral blood mononuclear cells from 90 chlamydia-infected women with
C. trachomatis
elementary bodies, Pgp3, and major outer membrane protein and measured IFN-γ-, tumor necrosis factor alpha (TNF-α)-, and interleukin-2 (IL-2)-producing CD4
+
and CD8
+
T-cell responses using intracellular cytokine staining. The majority of chlamydia-infected women elicited CD4
+
TNF-α responses, with frequency and magnitude varying significantly depending on the
C. trachomatis
antigen used. CD4
+
IFN-γ and IL-2 responses occurred infrequently, as did production of any of the three cytokines by CD8
+
T cells. About one-third of TNF-α-producing CD4
+
T cells coproduced IFN-γ or IL-2. In summary, the predominant Th1 cytokine response elicited to
C. trachomatis
infection in women was a CD4
+
TNF-α response, not CD4
+
IFN-γ, and a subset of the CD4
+
TNF-α-positive cells produced a second Th1 cytokine.
Funder
HHS | NIH | National Institute of Allergy and Infectious Diseases
HHS | NIH | National Center for Advancing Translational Sciences
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference49 articles.
1. World Health Organization. 2016. WHO guidelines for the treatment of Chlamydia trachomatis. World Health Organization,Geneva, Switzerland.
2. Centers for Disease Control and Prevention. 2015. Sexually transmitted disease surveillance 2014. Centers for Disease Control and Prevention,Atlanta, GA.
3. Modeling the Impact of Potential Vaccines on Epidemics of Sexually TransmittedChlamydia trachomatisInfection
4. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections
5. Chlamydia trachomatis control requires a vaccine
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献